{"transactions":[{"id":724992,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2026-06-29T20:21:16.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":93000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 25, 2027 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":93000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":93000},"source":{"system":"sec-edgar","filing":"0001838114-26-000002","document":"form4-06292026_080612.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000183811426000002/form4-06292026_080612.xml","form_type":"4"}},{"id":978437,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2025-12-08T21:20:35.000Z","date":"2025-12-04","kind":"sale","planned":false,"acquired":false,"shares":4166,"price":29.095,"value":121209.77,"ownership":{"direct":true},"balance_after":30796,"source":{"system":"sec-edgar","filing":"0001838114-25-000007","document":"form4-12082025_091231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000183811425000007/form4-12082025_091231.xml","form_type":"4"}},{"id":1065954,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2025-08-15T20:07:28.000Z","date":"2025-08-13","kind":"sale","planned":false,"acquired":false,"shares":430,"price":25.415,"value":10928.45,"ownership":{"direct":true},"balance_after":34962,"source":{"system":"sec-edgar","filing":"0001415889-25-022069","document":"form4-08152025_080825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925022069/form4-08152025_080825.xml","form_type":"4"}},{"id":1065953,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2025-08-15T20:07:28.000Z","date":"2025-08-13","kind":"sale","planned":false,"acquired":false,"shares":341,"price":23.9515,"value":8167.4615,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 269 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan."}],"balance_after":35392,"source":{"system":"sec-edgar","filing":"0001415889-25-022069","document":"form4-08152025_080825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925022069/form4-08152025_080825.xml","form_type":"4"}},{"id":1119014,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2025-06-09T20:18:04.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 5, 2026 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":75000,"derivative":{"exercise_price":19.53,"exercise_date":"2026-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-25-016244","document":"form4-06092025_080659.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925016244/form4-06092025_080659.xml","form_type":"4"}},{"id":1478185,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2024-06-17T20:19:47.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 13, 2025 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":75000,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-24-017190","document":"form4-06172024_080643.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017190/form4-06172024_080643.xml","form_type":"4"}},{"id":1487816,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2024-06-07T20:05:16.000Z","date":"2024-06-05","kind":"exercise","planned":false,"acquired":false,"shares":9540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":18454,"derivative":{"exercise_price":10.38,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":9540},"source":{"system":"sec-edgar","filing":"0001415889-24-015950","document":"form4-06072024_080609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015950/form4-06072024_080609.xml","form_type":"4"}},{"id":1487815,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2024-06-07T20:05:16.000Z","date":"2024-06-05","kind":"exercise","planned":false,"acquired":true,"shares":9540,"price":10.38,"value":99025.2,"ownership":{"direct":true},"balance_after":35464,"source":{"system":"sec-edgar","filing":"0001415889-24-015950","document":"form4-06072024_080609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015950/form4-06072024_080609.xml","form_type":"4"}},{"id":1491040,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2024-06-05T20:04:58.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":false,"shares":8006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":27994,"derivative":{"exercise_price":10.38,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":8006},"source":{"system":"sec-edgar","filing":"0001415889-24-015542","document":"form4-06052024_080652.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015542/form4-06052024_080652.xml","form_type":"4"}},{"id":1491039,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2024-06-05T20:04:58.000Z","date":"2024-06-03","kind":"sale","planned":false,"acquired":false,"shares":8006,"price":33.6001,"value":269002.4006,"ownership":{"direct":true},"balance_after":25924,"source":{"system":"sec-edgar","filing":"0001415889-24-015542","document":"form4-06052024_080652.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015542/form4-06052024_080652.xml","form_type":"4"}},{"id":1491038,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2024-06-05T20:04:58.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":true,"shares":8006,"price":10.38,"value":83102.28,"ownership":{"direct":true},"balance_after":33930,"source":{"system":"sec-edgar","filing":"0001415889-24-015542","document":"form4-06052024_080652.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015542/form4-06052024_080652.xml","form_type":"4"}},{"id":1642113,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2024-02-15T21:05:55.000Z","date":"2024-02-13","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"As of June 19, 2023, the option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.78,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-24-003891","document":"form4-02152024_090240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924003891/form4-02152024_090240.xml","form_type":"4"}},{"id":1642112,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2024-02-15T21:05:55.000Z","date":"2024-02-13","kind":"exercise","planned":false,"acquired":false,"shares":4166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On February 8, 2019, Celldex Therapeutics, Inc. effected a 1-for-15 reverse stock split of its common stock (the \"Reverse Stock Split\").  This option was previously reported as covering 62,500 shares at an exercise price of $0.6011 per share, but has been adjusted to reflect the Reverse Stock Split."},{"field":"shares","element":"transactionShares","label":"F1","text":"On February 8, 2019, Celldex Therapeutics, Inc. effected a 1-for-15 reverse stock split of its common stock (the \"Reverse Stock Split\").  This option was previously reported as covering 62,500 shares at an exercise price of $0.6011 per share, but has been adjusted to reflect the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of June 13, 2022, the option is fully vested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On February 8, 2019, Celldex Therapeutics, Inc. effected a 1-for-15 reverse stock split of its common stock (the \"Reverse Stock Split\").  This option was previously reported as covering 62,500 shares at an exercise price of $0.6011 per share, but has been adjusted to reflect the Reverse Stock Split."}],"balance_after":0,"derivative":{"exercise_price":9.0165,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":4166},"source":{"system":"sec-edgar","filing":"0001415889-24-003891","document":"form4-02152024_090240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924003891/form4-02152024_090240.xml","form_type":"4"}},{"id":1642111,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2024-02-15T21:05:55.000Z","date":"2024-02-13","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":2.78,"value":55600.0,"ownership":{"direct":true},"balance_after":25924,"source":{"system":"sec-edgar","filing":"0001415889-24-003891","document":"form4-02152024_090240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924003891/form4-02152024_090240.xml","form_type":"4"}},{"id":1642110,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2024-02-15T21:05:55.000Z","date":"2024-02-13","kind":"exercise","planned":false,"acquired":true,"shares":4166,"price":9.0165,"value":37562.739,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 8, 2019, Celldex Therapeutics, Inc. effected a 1-for-15 reverse stock split of its common stock (the \"Reverse Stock Split\").  This option was previously reported as covering 62,500 shares at an exercise price of $0.6011 per share, but has been adjusted to reflect the Reverse Stock Split."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 8, 2019, Celldex Therapeutics, Inc. effected a 1-for-15 reverse stock split of its common stock (the \"Reverse Stock Split\").  This option was previously reported as covering 62,500 shares at an exercise price of $0.6011 per share, but has been adjusted to reflect the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,328 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan."}],"balance_after":5924,"source":{"system":"sec-edgar","filing":"0001415889-24-003891","document":"form4-02152024_090240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924003891/form4-02152024_090240.xml","form_type":"4"}},{"id":1850851,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2023-06-20T20:17:20.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":74000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 15, 2024 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":74000,"derivative":{"exercise_price":36.87,"exercise_date":"2024-06-15","expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":74000},"source":{"system":"sec-edgar","filing":"0001415889-23-010045","document":"form4-06202023_080605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588923010045/form4-06202023_080605.xml","form_type":"4"}},{"id":2229184,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2022-06-17T20:18:26.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":73000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 16, 2023 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":73000,"derivative":{"exercise_price":22.48,"exercise_date":"2023-06-16","expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":73000},"source":{"system":"sec-edgar","filing":"0001415889-22-006732","document":"form4-06172022_010617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588922006732/form4-06172022_010617.xml","form_type":"4"}},{"id":2604673,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2021-08-13T10:58:39.000Z","date":"2021-08-11","kind":"purchase","acquired":true,"shares":430,"price":46.28,"value":19900.4,"ownership":{"direct":true},"balance_after":430,"source":{"system":"sec-edgar","filing":"0001179110-21-008163","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911021008163/edgar.xml","form_type":"4"}},{"id":2662455,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2021-06-21T20:29:59.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":73000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 17, 2022 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":73000,"derivative":{"exercise_price":28,"exercise_date":"2022-06-17","expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":73000},"source":{"system":"sec-edgar","filing":"0001179110-21-006912","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911021006912/edgar.xml","form_type":"4"}}]}